12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·2 days ago, 07:05 AMALT+2.05%OTLK+4.00%
Capital Rotations: A Record Biotech IPO and the Surging European Defense ETFGlobal Report·Jul 21 at 04:13 AMPBLS+1.57%GIS-3.96%
Aldeyra Therapeutics to seek Type D meeting with FDA on reproxalap NDA resubmissionTradingView·Jul 15 at 03:53 PMALDX-0.62%
Aldeyra Therapeutics CEO, President & Director Acquires 18% More StockSimplywall·Jun 10 at 08:18 AMALDX-0.62%
Aldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directors | ALDX Stock NewsStockTitan·Jun 9 at 11:30 AMALDX-0.62%
Aldeyra Therapeutics Eyes FDA Feedback as Dry Eye Drug Faces Make-or-Break MomentMarket Beat·Jun 4 at 08:02 PMALDX-0.62%
3 Promising Penny Stocks With Market Caps Reaching $300MSimplywall·Jun 4 at 12:16 PMBWEN+11.75%ZH-1.80%
Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference | ALDX Stock NewsStockTitan·Jun 1 at 10:01 PMALDX-0.62%
10:00 ETINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines - ALDXprnewswire·May 28 at 09:00 AMALDX-0.62%
03:44 ETAldeyra Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ALDXprnewswire·May 27 at 02:44 AMALDX-0.62%
20:02 ETALDX Deadline: ALDX Investors with Losses in Excess of $100K Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firmprnewswire·May 23 at 07:03 PMALDX-0.62%
